Ildiko Csiki, MD, PhD
Ildiko Csiki is the Vice President of Clinical Development at Inovio Pharmaceuticals where her primary interest is development of immunotherapies in oncology. Previously she was an Assistant Professor of Radiation Oncology at the University of Pennsylvania, where she was both a clinical and laboratory Principal Investigator and a clinician with an active practice. Her primary clinical interest has been lung cancer, but she also worked extensively on B cell malignancies and immunotherapies for GI malignancies during previous roles at GSK and Merck. She graduated magna cum laude from the University of Arkansas with degrees in Biology, Psychology and Chemistry and then received her MD and PhD degrees from Vanderbilt University. She also completed an internship in Internal Medicine and a residency in Radiation Oncology coupled with the Holman Research Fellowship at Vanderbilt.